BlackRock, Inc. 13D and 13G filings for IDEXX Laboratories, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | IDEXX Laboratories, Inc. IDXX |
BlackRock Inc. BLK |
7,599,078 9.400% |
-1,455,151 (-16.07%) |
Filing |
| 2024-01-24 09:46 am Purchase |
2023-12-31 | 13G | IDEXX Laboratories, Inc. IDXX |
BlackRock Inc. BLK |
9,054,229 10.900% |
551,348 (+6.48%) |
Filing |
| 2023-01-26 08:52 am Unchanged |
2022-12-31 | 13G | IDEXX Laboratories, Inc. IDXX |
BlackRock Inc. BLK |
8,502,881 10.300% |
0 (Unchanged) |
Filing |
| 2023-01-20 3:00 pm Sale |
2022-12-31 | 13G | IDEXX Laboratories, Inc. IDXX |
BlackRock Inc. BLK |
8,502,881 10.300% |
-487,705 (-5.42%) |
Filing |
| 2022-01-27 11:00 am Unchanged |
2021-12-31 | 13G | IDEXX Laboratories, Inc. IDXX |
BlackRock Inc. BLK |
8,990,586 10.600% |
0 (Unchanged) |
Filing |
| 2022-01-25 3:03 pm Purchase |
2021-12-31 | 13G | IDEXX Laboratories, Inc. IDXX |
BlackRock Inc. BLK |
8,990,586 10.600% |
378,181 (+4.39%) |
Filing |
| 2021-09-09 4:20 pm Purchase |
2021-08-31 | 13G | IDEXX Laboratories, Inc. IDXX |
BlackRock Inc. BLK |
8,612,405 10.100% |
722,813 (+9.16%) |
Filing |
| 2021-01-29 09:56 am Purchase |
2020-12-31 | 13G | IDEXX Laboratories, Inc. IDXX |
BlackRock Inc. BLK |
7,889,592 9.200% |
464,747 (+6.26%) |
Filing |